Kiruthikah Thillai

457 total citations
25 papers, 292 citations indexed

About

Kiruthikah Thillai is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hepatology. According to data from OpenAlex, Kiruthikah Thillai has authored 25 papers receiving a total of 292 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Hepatology. Recurrent topics in Kiruthikah Thillai's work include Renal cell carcinoma treatment (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Cancer Genomics and Diagnostics (6 papers). Kiruthikah Thillai is often cited by papers focused on Renal cell carcinoma treatment (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Cancer Genomics and Diagnostics (6 papers). Kiruthikah Thillai collaborates with scholars based in United Kingdom, United States and Norway. Kiruthikah Thillai's co-authors include Claire M. Wells, Debashis Sarker, Paul J. Ross, Hoyin Lam, Ole Morten Seternes, Mark Holt, Bjarne Johansen, Saoirse Dolly, Hesham Eldaly and Andrew Whale and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Kiruthikah Thillai

24 papers receiving 290 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kiruthikah Thillai United Kingdom 12 159 127 65 62 40 25 292
Arya Mariam Roy United States 10 114 0.7× 170 1.3× 79 1.2× 87 1.4× 21 0.5× 74 355
Tao Pan China 8 79 0.5× 94 0.7× 71 1.1× 46 0.7× 23 0.6× 24 259
Akira Okimura Japan 8 112 0.7× 141 1.1× 49 0.8× 82 1.3× 11 0.3× 28 290
James P. De Andrade United States 12 195 1.2× 134 1.1× 85 1.3× 100 1.6× 11 0.3× 25 400
Keiji Nishibeppu Japan 10 224 1.4× 94 0.7× 186 2.9× 122 2.0× 36 0.9× 51 424
Francesco Caprioni Italy 8 109 0.7× 177 1.4× 51 0.8× 56 0.9× 22 0.6× 13 331
Paul Mésange France 6 91 0.6× 68 0.5× 45 0.7× 89 1.4× 24 0.6× 12 224
Zhi‐Gang Sun China 12 155 1.0× 87 0.7× 73 1.1× 94 1.5× 9 0.2× 46 369
Maria M. Rubinstein United States 10 82 0.5× 105 0.8× 50 0.8× 44 0.7× 23 0.6× 26 304
Hideko Isozaki Japan 9 209 1.3× 207 1.6× 54 0.8× 198 3.2× 20 0.5× 31 374

Countries citing papers authored by Kiruthikah Thillai

Since Specialization
Citations

This map shows the geographic impact of Kiruthikah Thillai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kiruthikah Thillai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kiruthikah Thillai more than expected).

Fields of papers citing papers by Kiruthikah Thillai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kiruthikah Thillai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kiruthikah Thillai. The network helps show where Kiruthikah Thillai may publish in the future.

Co-authorship network of co-authors of Kiruthikah Thillai

This figure shows the co-authorship network connecting the top 25 collaborators of Kiruthikah Thillai. A scholar is included among the top collaborators of Kiruthikah Thillai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kiruthikah Thillai. Kiruthikah Thillai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dolly, Saoirse, et al.. (2023). Pancreatic cancer and depression. World Journal of Clinical Cases. 11(12). 2631–2636. 13 indexed citations
2.
Russell, Beth, Charlotte Moss, Elke Rammant, et al.. (2022). Cancer staff in an NHS cancer center: infections, vaccination, stress and well-being support during the COVID-19 pandemic. Future Oncology. 18(18). 2201–2216. 1 indexed citations
3.
Dolly, Saoirse, et al.. (2021). Pancreatic Cancer Exposome Profile to Aid Early Detection and Inform Prevention Strategies. Journal of Clinical Medicine. 10(8). 1665–1665. 11 indexed citations
4.
Russell, Beth, Charlotte Moss, Kieran Palmer, et al.. (2021). COVID-19 infection in gastrointestinal (GI) cancer patients receiving systemic anticancer treatment (SACT) during the outbreak of the pandemic: The Guy's Cancer Centre experience.. Journal of Clinical Oncology. 39(3_suppl). 455–455. 1 indexed citations
5.
Benepal, T., et al.. (2019). Cancer, mental health and end life simulation (CAMhELS): A novel effectiveness evaluation. Annals of Oncology. 30. v669–v669. 1 indexed citations
6.
Josephs, Debra H., A. Kulkarni, Mikel Valgañón, et al.. (2019). A retrospective analysis of 66 colorectal cancer cases from Guy’s and St Thomas’ (GSTT) Molecular Tumour Board. Annals of Oncology. 30. vii9–vii9.
7.
O’Brien, Mary, Debashis Sarker, Jaishree Bhosle, et al.. (2018). A phase I study to assess afatinib in combination with carboplatin or with carboplatin plus paclitaxel in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 82(5). 757–766. 3 indexed citations
8.
Thillai, Kiruthikah, Debashis Sarker, & Claire M. Wells. (2018). PAK4 Pathway as a Potential Therapeutic Target in Pancreatic Cancer. Future Oncology. 14(7). 579–582. 13 indexed citations
9.
King, Helen, Kiruthikah Thillai, Andrew Whale, et al.. (2017). PAK4 interacts with p85 alpha: implications for pancreatic cancer cell migration. Scientific Reports. 7(1). 42575–42575. 37 indexed citations
10.
Thillai, Kiruthikah, Debashis Sarker, & Claire M. Wells. (2017). PAK4 as a potential therapeutic target in pancreatic ductal adenocarcinoma (PDAC).. Journal of Clinical Oncology. 35(15_suppl). e23139–e23139. 1 indexed citations
11.
Thillai, Kiruthikah, et al.. (2017). Regorafenib as treatment for patients with advanced hepatocellular cancer. Future Oncology. 13(25). 2223–2232. 12 indexed citations
12.
Thillai, Kiruthikah, Abid Suddle, Nigel Heaton, et al.. (2017). Application of ALBI and PALBI score as prognostic variables in hepatocellular carcinoma patients treated with transarterial-chemoembolization.. Journal of Clinical Oncology. 35(4_suppl). 241–241. 1 indexed citations
13.
Thillai, Kiruthikah, Dimitra Repana, Ippokratis Korantzis, et al.. (2016). Clinical outcomes for patients with liver-limited metastatic colorectal cancer: Arguing the case for specialist hepatobiliary multidisciplinary assessment. European Journal of Surgical Oncology. 42(9). 1331–1336. 9 indexed citations
14.
Thillai, Kiruthikah. (2016). Molecularly targeted therapy for advanced hepatocellular carcinoma - a drug development crisis?. World Journal of Gastrointestinal Oncology. 8(2). 173–173. 26 indexed citations
15.
Thillai, Kiruthikah, et al.. (2015). A novel role for atypical MAPK kinase ERK3 in regulating breast cancer cell morphology and migration. Cell Adhesion & Migration. 9(6). 483–494. 51 indexed citations
16.
Thanopoulou, Eirini, Alicia Okines, Kiruthikah Thillai, et al.. (2014). Febrile Neutropaenia and Chemotherapy Discontinuation in Women Aged 70 Years or Older Receiving Adjuvant Chemotherapy for Early Breast Cancer. Clinical Oncology. 26(11). 692–696. 10 indexed citations
17.
Papadatos-Pastos, D., Kiruthikah Thillai, Roy Rabbie, Paul J. Ross, & Debashis Sarker. (2014). FOLFIRINOX – a new paradigm in the treatment of pancreatic cancer. Expert Review of Anticancer Therapy. 14(10). 1115–1125. 13 indexed citations
18.
Thillai, Kiruthikah, Suzanne Allan, Thomas Powles, Sarah Rudman, & Simon Chowdhury. (2012). Neoadjuvant and adjuvant treatment of renal cell carcinoma. Expert Review of Anticancer Therapy. 12(6). 765–776. 16 indexed citations
19.
Fisher, Rosalie, Alexandra Pender, Kiruthikah Thillai, et al.. (2012). Observation as a treatment strategy for advanced renal cell carcinoma—a call for prospective validation. SHILAP Revista de lepidopterología. 2. 155–155. 18 indexed citations
20.
Fisher, Rosalie, Alexandra Pender, Kiruthikah Thillai, et al.. (2011). Observation prior to systemic therapy in patients with metastatic renal cell carcinoma in the kinase inhibitor era.. Journal of Clinical Oncology. 29(15_suppl). 4630–4630. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arya Mariam Roy Breakdown of academic impact, for papers by Tao Pan Breakdown of academic impact, for papers by Akira Okimura Breakdown of academic impact, for papers by James P. De Andrade Breakdown of academic impact, for papers by Keiji Nishibeppu Breakdown of academic impact, for papers by Francesco Caprioni Breakdown of academic impact, for papers by Paul Mésange Breakdown of academic impact, for papers by Zhi‐Gang Sun Breakdown of academic impact, for papers by Maria M. Rubinstein Breakdown of academic impact, for papers by Hideko Isozaki
Rankless by CCL
2026